Erck Stanley C
- SEC CIK
- 0001342826
No open-market purchases or sales filed in the past year.
Current role at each company
- MXCT Maxcyte, Inc.Directoras of Jun 22, 2026
- NVAX Novavax IncPresident and CEOas of Dec 16, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Erck Stanley C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MXCT Maxcyte, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2024 (view filing)5:10 PM ET | Sep 3-4 | 2 days | Erck Stanley CDirector | SSale | −47.7K | $4.02 | −$191.7K | −15.1%269.1K after | 2 lots10b5-1 |
| Oct 2, 2024 (view filing)5:03 PM ET | Oct 1-2 | 1 day | Erck Stanley CDirector | SSale | −47.7K | $3.75 | −$178.8K | −15.1%269.1K after | 2 lots10b5-1 |
| Nov 5, 2024 (view filing)4:25 PM ET | Nov 1 | 4 days | Erck Stanley CDirector | SSale | −47.7K | $3.72 | −$177.4K | −15.1%269.1K after | 10b5-1 |
| Aug 13, 2025 (view filing) | Aug 13 | Same day | Erck Stanley CDirector | PPurchase | +100.0K | $1.37 | +$137.0K | +33.5%398.3K after |
NVAX Novavax Inc
President and CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2021 (view filing) | Jul 1-2 | 5 days | Erck Stanley CPresident and CEO | SSale | −105.2K | $214.38 | −$22.5M | −83.7%20.5K after | 20 lots |
| Oct 5, 2021 (view filing) | Oct 1 | 4 days | Erck Stanley CPresident and CEO | SSale | −49.0K | $175.10 | −$8.58M | −67.2%23.9K after | 23 lots |
| Oct 5, 2021 (view filing) | Oct 4 | 1 day | Erck Stanley CPresident and CEO | SSale | −42.8K | $176.15 | −$7.54M | −64.2%23.9K after | 10 lots |